Skip to main content
CHAMPIONS ONCOLOGY, INC. logo

CHAMPIONS ONCOLOGY, INC. — Investor Relations & Filings

Ticker · CSBR ISIN · US15870P3073 LEI · 549300O8WKLP8QEG5U47 US Professional, scientific and technical activities
Filings indexed 969 across all filing types
Latest filing 2026-03-30 Regulatory Filings
Country US United States of America
Listing US CSBR

About CHAMPIONS ONCOLOGY, INC.

https://championsoncology.com

Champions Oncology, Inc. is a technology-enabled contract research organization (CRO) providing end-to-end solutions to accelerate oncology drug development. The company partners with pharmaceutical and biotechnology firms, offering a range of preclinical and clinical research services. Its core offering is an extensive, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models used for in vivo and ex vivo efficacy studies. These models are supported by a comprehensive multi-omic data platform that provides genomic, transcriptomic, and proteomic insights for model selection and biomarker discovery. Additionally, Champions Oncology operates as a clinical specialty laboratory, providing advanced analytical services such as high-complexity flow cytometry, next-generation sequencing, and histology to support clinical trials.

Recent filings

Filing Released Lang Actions
8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Regulatory Filings
2026-03-30 English
4 Filing
Director's Dealing
2026-01-30 English
4 Filing
Director's Dealing
2026-01-30 English
3 Filing
Director's Dealing
2026-01-16 English
8-K Filing
Regulatory Filings
2025-12-15 English
10-Q Filing
Interim / Quarterly Report Q2 2026
2025-12-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.